Back to Show
PBS News Hour
FDA criticized for Alzheimer's drug approval process
New findings from a congressional investigation into the Food and Drug Administration and the biotech company Biogen find the FDA broke its own protocols to approve a new Alzheimer’s drug last year. The report said the FDA worked too closely with Biogen despite significant concerns over the limited benefits and side effects of the new drug, Aduhelm. Geoff Bennett reports.
Support Provided By
57:46
February 20, 2026 - PBS News Hour full episode
57:46
February 19, 2026 - PBS News Hour full episode
57:46
February 18, 2026 - PBS News Hour full episode
57:46
February 17, 2026 - PBS News Hour full episode
57:46
February 16, 2026 - PBS News Hour full episode
57:46
February 13, 2026 - PBS News Hour full episode
57:46
February 12, 2026 - PBS News Hour full episode
57:46
February 11, 2026 - PBS News Hour full episode
57:46
February 10, 2026 - PBS News Hour full episode
56:45
February 9, 2026 - PBS News Hour full episode
57:46
February 6, 2026 - PBS News Hour full episode
57:46
February 5, 2026 - PBS News Hour full episode